DOI QR코드

DOI QR Code

Suppression of brown blotch disease by tolaasin inhibitory factors

톨라신 저해 물질을 이용한 갈반병의 억제

  • Yun, Yeong-Bae (Department of Environmental and Biological Chemistry, Chungbuk National University) ;
  • Kim, Min-Hee (Department of Environmental and Biological Chemistry, Chungbuk National University) ;
  • Han, Ji-Hye (Department of Environmental and Biological Chemistry, Chungbuk National University) ;
  • Kim, Young-Kee (Department of Environmental and Biological Chemistry, Chungbuk National University)
  • Received : 2017.06.09
  • Accepted : 2017.06.15
  • Published : 2017.06.30

Abstract

Tolaasin, a 1.9 kDa peptide toxin, is produced by Pseudomonas tolaasii and causes the brown blotch disease of cultivated oyster mushroom. It forms pores on the membrane and thus destroys cellular membrane structure, seriously reducing the productivity of mushroom cultivation. The mechanism of tolaasin-induced cytotoxicity is not known in detail. However, it has been reported to form a pore structure in the cytoplasmic membrane through the molecular multimerization. Therefore, food additives which can interact with tolaasin molecules may inhibit the pore formation by hydrophobic interactions with tolaasin molecules. In this study, various food additive materials have been identified as inhibitors of the tolaasin activity and named tolaasin-inhibitory factors (TIF). Most of TIFs are emulsifying agents for food processing procedures. Among various TIFs, polyglycerol and sucrose esters of fatty acids blocked effectively the cytotoxicity of tolaasins at the concentrations $10^{-4}-10^{-5}M$. These TIFs also successfully suppressed the blotch disease development in the shelf cultivation of oyster mushroom.

톨라신은 1.9 kDa의 펩티드 독소로서 Pseudomonas tolaasii에 의해 생성되며, 재배중 느타리버섯에 갈반병을 일으킨다. 톨라신은 막에 pore를 형성하여 세포 구조를 파괴하고, 버섯 재배의 생산성을 심하게 감소시킨다. 톨라신에 의한 세포독성의 작용 기작은 완전히 밝혀지지 않았지만, 분자다중화에 의해 세포막에 채널구조 형성으로 이루어진다. 그러므로, 톨라신과 작용하는 식품첨가물 중에 톨라신의 다중화결합을 통한 세포막 pore 형성을 저해하는 물질이 있을 것이다. 본 연구에서는, 다양한 물질들이 톨라신의 활성을 저해함을 확인하고, 이들을 톨라신 저해물질(TIF)이라 명명하였다. 대부분의 톨라신 저해물질들은 식품가공과정에 쓰이는 유화제였다. 다양한 종류의 저해물질 중에 지방산과 에스터 결합한 polyglycerol과 지방산과 에스터 결합한 sucrose 화합물이 $10^{-4}-10^{-5}M$ 농도범위에서 톨라신의 세포독성을 효과적으로 저해하였다. 이러한 저해물질들은 균상재배하는 느타리버섯에서 갈반병의 발생을 성공적으로 억제하였다.

Keywords

References

  1. Cho KH, Kim ST, Kim YK (2006) Inhibitory effect of $Zn^{2+}$ on tolaasininduced hemolysis. J Korean Soc Appl Biol Chem 49: 281-286
  2. Cho KH, Kim YK (2003) Two types of ion channel formation of tolaasin, a Pseudomonas peptide toxin. FEMS Microbiol Lett 221: 221-226 https://doi.org/10.1016/S0378-1097(03)00182-4
  3. Cho KH, Park KS, Kim YK (2000) Hemolytic properties of tolaasin causing the brown blotch disease on oyster mushroom. J Korean Soc Agric Chem Biotechnol 43: 190-195
  4. Desai DA, Kukreja GP, Raorane CJ, Patil SB (2016) Partial sequencing of serendipitously isolated antifungal producer, Pseudomonas tolaasii strain GD76 16s ribosomal RNA gene. Int J Curr Microbiol App Sci 5: 455-458 https://doi.org/10.20546/ijcmas.2016.511.052
  5. Gandy DG (1968) A technique for screening bacteria causing brown blotch of cultivated mushrooms. Annual Report of the Glasshouse Crops Research Institute for 1967, 150-154
  6. Geels FP (1995) Pseudomonas tolaasii control by kasugamycin in cultivated mushroom(Agaricus bisporus). J Appl Microbiol 79: 38-42
  7. Geels FP, van Griensven LD, Rutjens AJ (1991) Chlorine dioxide and the control of bacterial blotch on mushrooms, caused by Pseudomonas tolaasii. In: Maher MJ (ed) Mushroom Science XIII, science and cultivation of edible mushrooms, Balkema, Rotterdam, pp 437-442
  8. Hutchison MI, Johnstone K (1993) Evidence for the involvement of the surface active properties of the extracellular toxin tolaasin in the manifestation of brown blotch disease symptoms by Pseudomonas tolaasii on Agaricus bisporus. Physiol Mol Plant Pathol 42: 273-384
  9. Jolivet S, Voiland A, Pellon G, Arpin N (1995) Main factors involved in the browning of Agaricus bisporus. In: Elliot TJ (ed) Mushroom Science XIV, science and cultivation of edible mushrooms, Balkema, Rotterdam, pp 695-702
  10. Kim JW, Kim KH, Kang HJ (1994) Studies on the pathogenic Pseudomonas causing bacterial disease of cultivated mushroom in Korea: 1. On the causal organisms of the rots of Agaricus bisporus, Pleurotus ostreatus, and Lentinus edodes. Korean J Plant Pathol 10: 197-210
  11. Kim MH, Park SW, Kim YK (2011) Bacteriophages of Pseudomonas tolaasii for the biological control of brown blotch disease. J Korean Soc Appl Biol Chem 54: 99-104
  12. Kuroda Y, Maeda Y, Sawa S, Shibata K, Miyamoto K, Nakagawa T (2003) Effects of detergent on the secondary structures of prion protein peptides as studied by CD spectroscopy. J Pept Sci 9: 212-220 https://doi.org/10.1002/psc.447
  13. Lee HI, Lee SD, Park KS, Kim YK, Cha JS (1997) Pathogenicity of bacterial isolates from brown blotch-diseased oyster mushrooms in Chungcheungbukdo. J Agric Sci Chungbuk Nat'l Univ 14: 121-132
  14. Lee HJ (2017) Inhibition of green mold diseases on oak mushroom using antifungal peptides. Dissertation, Chungbuk National University
  15. Mu LL, Yun YB, Park SJ, Cha JS, Kim YK (2015) Various pathogenic Pseudomonas strains that cause brown blotch disease in cultivated mushrooms. J Appl Biol Chem 58: 349-354 https://doi.org/10.3839/jabc.2015.055
  16. Nazari M, Kurdi M, Heerklotz H (2012) Classifying surfactants with respect to their effect on lipid membrane order. Biophys J 102: 498-506 https://doi.org/10.1016/j.bpj.2011.12.029
  17. Nepal O, Rao JP (2011) Haemolytic effects of hypo-osmotic salt solutions on human erythrocytes. Kathmandu Univ Med J 34: 35-39
  18. Nielson TH, Sorensen C, Tobiasen JB, Andersen C, Christophersen C, Givskov M, Sorensen J (2002) Antibiotic and biosurfactant properties of cycle lipopeptides produced by fluorescent Pseudomonas spp. From the sugar beet rhizosphere. Appl Env Microbiol 68: 3416-3423 https://doi.org/10.1128/AEM.68.7.3416-3423.2002
  19. Nybroe O, Sorensen J (2004) Production of cyclic lipopeptides by fluorescent pseudomonads. In: JL Ramos (ed), Pseudomonas, biosynthesis of macromolecules and molecular metabolism, New York, pp 147-172
  20. Peng JT (1986) Resistance to disease in Agaricus bisporus(lange). Dissertation, University of Leeds
  21. Rainey PB, Brodey CL, Johnstone K (1991) Biological properties and spectrum of activity of tolaasin, a lipodepsipeptide toxin produced by the mushroom pathogen Pseudomonas tolaasii. Physiol Mol Plant Pathol 39: 57-70 https://doi.org/10.1016/0885-5765(91)90031-C
  22. Shabestari MH, Neeuwenoord NJ, Filippov DV, Huber M (2016) Interaction of the amyloid ${\beta}$ peptide with sodium dodecyl sulfate as a membranemimicking detergent. J Biol Phys 42: 299-315 https://doi.org/10.1007/s10867-016-9408-5
  23. Shin GC, Jeon NB (1991) Identification of yellow blotch bacteria of oyster mushroom and its biological by antagonistic bacteria. Research Reports of the Rural Development Administration 34, 1-10
  24. Sjogren H, Ericsson CA, Evenas J, Ulvenlund S (2005) Interactions between charged polypeptides and nonionic surfactants. Biophys J 89: 4219-4233 https://doi.org/10.1529/biophysj.105.065342
  25. Soler-Rivas C, Moller AC, Arpin N, Olivier JM, Wichers HJ (2001) Induction of a tyrosinase mRNA in Agaricus bisporus upon treatment with a tolaasin preparation from Pseudomonas tolaasii. Physio Mol Plant Pathol 58: 95-99 https://doi.org/10.1006/pmpp.2000.0312
  26. Soulier L, Foret V, Arpin N (1993) Occurrence of agaritine and ${\gamma}$-glutaminyl-4-hydroxybenzene (GHB) in the fructifying mycelium of Agaricus bisporus. Mycol Res 97: 529-532 https://doi.org/10.1016/S0953-7562(09)81174-X
  27. Tajalipour S, Hassanzadeh N, Jolfaee HK, Heydari A, Hasemi A (2014) Biological control of mushroom brown blotch disease using antagonistic bacteria. Biocontrol Sci Technol 24: 473-484 https://doi.org/10.1080/09583157.2013.873113
  28. Tolaas (1915) A Bacterial disease of cultivated mushrooms. Phytopathol 5: 51-54
  29. Wong WC, Preece TF (1985) Pseudomonas tolaasii in cultivated mushroom (Agaricus bisporus) crops: effects of sodium hypochlorite on the bacterium and on blotch disease severity. J Appl Microbiol 58: 259-267

Cited by

  1. Stability increase in the activity of tolaasin inhibitors under reducing conditions vol.60, pp.4, 2017, https://doi.org/10.3839/jabc.2017.055
  2. Zn2+와 Ni2+에 의한 톨라신 용혈활성 저해효과의 pH 의존성 vol.61, pp.3, 2017, https://doi.org/10.3839/jabc.2018.031
  3. 100 Years Since Tolaas: Bacterial Blotch of Mushrooms in the 21st Century vol.103, pp.11, 2017, https://doi.org/10.1094/pdis-03-19-0589-fe